Skip to Main Content

Author Details

Robert B Den
Thomas Jefferson University Hospital
1999
173
45
PMIDPaper TitleJournal TitlePublished Year
36579470Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.Cancer2023
37568788Innate Immune System in the Context of Radiation Therapy for Cancer.Cancers (Basel)2023
37060201A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.Cancer2023
37344462Enhancing bladder cancer care through the multidisciplinary clinic approach.Can J Urol2023
33303244Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.Eur Urol2022
35638091Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race.Eur Urol Open Sci2022
36237307Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.Front Oncol2022
36077840Bone Health Management in the Continuum of Prostate Cancer Disease.Cancers (Basel)2022
34538726Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy.Urol Oncol2022
34481017Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial.Int J Radiat Oncol Biol Phys2022
33037017Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.Clin Cancer Res2021
35475294Impact of Decipher on use of post-operative radiotherapy: Individual patient analysis of two prospective registries.BJUI Compass2021
33879449RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.Cancer Discov2021
33928239Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases.J Transl Genet Genom2021
33531653A comparative study of PCS and PAM50 prostate cancer classification schemes.Prostate Cancer Prostatic Dis2021
34380009Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional Experience.Int J Radiat Oncol Biol Phys2021
34129855Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial.Ann Oncol2021
34083737Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.Commun Biol2021
33998599Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.J Clin Invest2021
33246636Radiopharmaceuticals for Bone Metastases.Semin Radiat Oncol2021
31369886Overemphasis of Step 1 Scores May Affect Application Pool Diversity in Radiation Oncology.Pract Radiat Oncol2020
35050780Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate.JCO Precis Oncol2020
31909533Increased expression of desmin and vimentin reduces bladder smooth muscle contractility via JNK2.FASEB J2020
31813810Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Focus2020
32029346Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer.Int J Radiat Oncol Biol Phys2020
31639361Feasibility and Impact of Emotional Intelligence Evaluation in Radiation Oncology Residency Interviews.J Am Coll Radiol2020
31693508A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer.Am J Clin Oncol2020
31719663Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.Prostate Cancer Prostatic Dis2020
31829902Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.J Clin Oncol2020
31977382Comparing Radiotherapy to Prostatectomy for High-Risk Prostate Cancer: A Narrative Review of Mortality and Quality-of-Life Outcomes.Cancer J2020
31976607Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisions.Head Neck2020
32250729Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.J Urol2020
32217038A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer.Brachytherapy2020
32215583Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.JAMA Oncol2020
32553790Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice.Urol Oncol2020
32516092Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.J Clin Oncol2020
32461072Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.Eur Urol2020
32231245Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.Prostate Cancer Prostatic Dis2020
32192889Prognostic value of the SPOP mutant genomic subclass in prostate cancer.Urol Oncol2020
31455846Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.Prostate Cancer Prostatic Dis2020
30381857Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.Prostate2019
31850194Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions.Front Oncol2019
30119882Avoidance sectors to reduce dosimetric impact of an irreproducible pannus on setup uncertainty in prostate SBRT VMAT: A case study.Med Dosim2019
31411980Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.Eur Urol Oncol2019
31466944CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.Cancer Discov2019
31515456Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.Clin Cancer Res2019
31255477The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States.Clin Colorectal Cancer2019
31125117Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.Int J Cancer2019
30707892NF-κB and GATA-Binding Factor 6 Repress Transcription of Caveolins in Bladder Smooth Muscle Hypertrophy.Am J Pathol2019
31107158African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.J Urol2019
  • 1 - 50 of 173

Recommended Authors

Luca F Valle
University of California los angeles
Career Start Year 2016
Number of shared co-authors 35
Jesus E Juarez
University of California Los Angeles
Career Start Year 2015
Number of shared co-authors 29
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 17
Stephen Greco
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 41
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 21
Ting Martin Ma
University of Washington
Career Start Year 2010
Number of shared co-authors 45
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 40
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 4
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 19
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 17
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 34
Albert J Chang
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 35
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 57
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 16
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 4
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 29
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 34
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 32
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 18
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 30
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 18
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 20
Michael L Steinberg
University of California los angeles
Career Start Year 1996
Number of shared co-authors 51
Jay P Ciezki
Cleveland Clinic
Career Start Year 1995
Number of shared co-authors 31
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 33
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 35
Patrick A Kupelian
university of california los angeles Medical Center
Career Start Year 1993
Number of shared co-authors 42
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 49
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 55
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 28

Collaborators

Elai Davicioni
Veracyte Inc.
Co-authored papers 58
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 40
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 39
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 36
Eric A Klein
Cleveland Clinic
Co-authored papers 33
Ashley E Ross
Northwestern University
Co-authored papers 31
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 23
Nicholas Erho
GenomeDx Biosciences Inc.
Co-authored papers 22
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 21
Stephen J Freedland
Cedars-Sinai Medical Center
Co-authored papers 21
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 20
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Co-authored papers 18
Yang Liu
Veracyte inc.
Co-authored papers 14
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 11
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 11
Mandeep Takhar
GenomeDx Biosciences Inc.
Co-authored papers 10
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 8
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 7
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 7
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 7
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 7
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 6
Alan Pollack
University of Miami Miller School of Medicine
Co-authored papers 6
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 6
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 6
Lucia L Lam
School of Clinical Medicine, University of Hong Kong, Queen Mary Hospital
Co-authored papers 6
William Robert Lee
Duke University School of Medicine
Co-authored papers 5
Robert T Dess
University of Michigan ann arbor
Co-authored papers 5
Sheila Weinmann
Center for Health Research, Kaiser Permanente Northwest Research Center
Co-authored papers 5
Thomas M Pisansky
Mayo Clinic
Co-authored papers 5
Release 1.2